Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Menopause can lead to skin and hair problems due to hormonal changes, but hormone replacement therapy might help slow these effects.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

In late pregnancy, allopregnanolone reduces stress responses in rats by affecting brain chemicals.

Spironolactone most effective for hirsutism, but has side effects.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

After menopause, women lose a lot of skin collagen, but estrogen replacement might improve skin health.

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

RANK-RANKL signaling is essential for hair growth and skin health.

Finasteride helps reduce heart issues and improves heart function.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Adrenal disorders can cause lasting brain and behavior issues in children.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Combining cosmetic procedures with lifestyle changes improves antiaging results.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.